Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rasi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|May 11, 1999
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesisF Guadagni, P Graziano, M Roselli, et al.
Melanoma Research|May 10, 2000
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanomaG Rasi, E Terzoli, F Izzo, et al.
International Journal of Cancer|June 1, 1994
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in ratsG Rasi, G Silecchia, P Sinibaldi-Vallebona, et al.
Anticancer Research|September 2, 1999
Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?A Serafino, P Sinibaldi-Vallebona, P Pierimarchi, et al.
Gut|November 1, 1996
Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis CG Rasi, D DiVirgilio, M G Mutchnick, et al.
Journal of Viral Hepatitis|July 1, 1996
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis BG Rasi, M G Mutchnick, D Di Virgilio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2aE Garaci, M Lopez, G Bonsignore, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil deliveryG Silecchia, E Guarino, P Sinibaldi-Vallebona, et al.
International Journal of Cancer|March 4, 2000
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cellsG Rasi, P Sinibaldi-Vallebona, A Serafino, et al.
Experimental Cell Research|January 27, 2009
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformationA Serafino, E Balestrieri, P Pierimarchi, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|May 11, 1999
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesisF Guadagni, P Graziano, M Roselli, et al.
Melanoma Research|May 10, 2000
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanomaG Rasi, E Terzoli, F Izzo, et al.
International Journal of Cancer|June 1, 1994
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in ratsG Rasi, G Silecchia, P Sinibaldi-Vallebona, et al.
Anticancer Research|September 2, 1999
Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?A Serafino, P Sinibaldi-Vallebona, P Pierimarchi, et al.
Gut|November 1, 1996
Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis CG Rasi, D DiVirgilio, M G Mutchnick, et al.
Journal of Viral Hepatitis|July 1, 1996
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis BG Rasi, M G Mutchnick, D Di Virgilio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2aE Garaci, M Lopez, G Bonsignore, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 1999
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil deliveryG Silecchia, E Guarino, P Sinibaldi-Vallebona, et al.
International Journal of Cancer|March 4, 2000
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cellsG Rasi, P Sinibaldi-Vallebona, A Serafino, et al.
Experimental Cell Research|January 27, 2009
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformationA Serafino, E Balestrieri, P Pierimarchi, et al.
Pageof 4